Consistently, we found that ROS and NADPH levels were lower and higher, respectively, in the resistant tumor cells, compared with the control unresistant cells, which were further enhanced by DDP treatment, concomitant with AHR sulfenylation and colocalization with PTG of the glycogen complex (Figure 6, P and Q). The gene discussed is PPP1R3C; the disease is neoplasm.